{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027499","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-06-05T20:30:44+00:00","discovered_at":"2026-06-05T20:32:00.239456+00:00","generated_at":"2026-06-05T20:40:21.059424+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Indaptus Therapeutics announces resignation of two directors and COO; COO to serve as consultant","bullets":["David E. Lazar and Avraham Ben-Tzvi resigned from all director positions and committees effective June 5, 2026.","Walt A. Linscott resigned as COO effective June 1, 2026, and will serve as consultant under a consulting agreement.","Resignations were not due to any disagreement with the company's operations, policies, or practices.","No replacements for directors or COO were announced; CEO Junyi Dai remains in place."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027499","json":"https://secwatch.observer/filing/0001493152-26-027499.json","markdown":"https://secwatch.observer/filing/0001493152-26-027499.md","text":"https://secwatch.observer/filing/0001493152-26-027499.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:40:21.059424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05e1303840","claim":"David E. Lazar resigned as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"Effective as of June 5, 2026, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi resigned from all directorship positions, including from all committees served, on the Board of Directors (the “ Board ”) of Indaptus Therapeutics, Inc. (the “ Company ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1129288061","claim":"Walt A. Linscott resigned as Chief Operating Officer at Indaptus Therapeutics, Inc..","evidence_excerpt":"Effective as of June 1, 2026, Mr. Walt A. Linscott, Esq. resigned as the Chief Operating Officer of the Company, and, pursuant to a consulting agreement with the Company dated June 1, 2026, will serve as a consultant for the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"2ebcc83090","claim":"Avraham Ben-Tzvi resigned as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"Effective as of June 5, 2026, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi resigned from all directorship positions, including from all committees served, on the Board of Directors (the “ Board ”) of Indaptus Therapeutics, Inc. (the “ Company ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}